Effectiveness of the switch from insulin to incretin therapy in patients with long-lasting type 2 diabetes: a 6-month longitudinal, real-life study

被引:0
|
作者
Citarrella, R. [1 ]
Di Vittorio, M. [1 ]
Bonfiglio, A. [1 ]
Speciale, S. [1 ]
Ruggirello, D. [1 ]
Castellino, G. [1 ]
Chianetta, R. [1 ]
Nikolic, D. [1 ]
Mannina, C. [1 ]
Montalto, G. [1 ]
机构
[1] Univ Palermo, DIBIMIS, Palermo, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
744
引用
收藏
页码:S363 / S363
页数:1
相关论文
共 50 条
  • [41] Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes
    Okamoto, Takashi
    Okamoto, Lisa
    Lisanti, Michael P.
    Akishita, Masahiro
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2008, 8 (04) : 218 - 226
  • [42] Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes -: Results of a 6-month, randomized, comparative trial
    Quattrin, T
    Bélanger, A
    Bohannon, NJV
    Schwartz, SL
    DIABETES CARE, 2004, 27 (11) : 2622 - 2627
  • [43] Safety and efficacy of insulin detemir treatment in elderly type 2 patients:: 6-month results from PREDICTIVE™
    Dornhorst, Anne
    Virkamaki, Antti
    Hansen, Jes B.
    Hernandez, Francisco
    DIABETES, 2007, 56 : A557 - A557
  • [44] Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use
    Seufert, Jochen
    Freemantle, Nick
    Guja, Cristian
    Haluzik, Martin
    Tournay, Mathilde
    Vera, Carine
    Bonnemaire, Mireille
    Kis, Janos T.
    DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2988 - 2992
  • [45] Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: Results from the DIALOG study
    Cariou, B.
    Fontaine, P.
    Eschwege, E.
    Lievre, M.
    Gouet, D.
    Huet, D.
    Madani, S.
    Lavigne, S.
    Charbonnel, B.
    DIABETES & METABOLISM, 2015, 41 (02) : 116 - 125
  • [46] Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study (vol 18, 365, 2018)
    Schoettle, Daniel
    Janetzky, Wolfgang
    Luedecke, Daniel
    Beck, Elmar
    Correll, Christoph U.
    Wiedemann, Klaus
    BMC PSYCHIATRY, 2018, 18
  • [47] SWITCH TO BUDESONIDE/FORMOTEROL EASYHALER INHALATION THERAPY FROM OTHER INHALERS IN COPD PATIENTS; A REAL-LIFE STUDY
    Galffy, G.
    Szilasi, M.
    THORAX, 2018, 73 : A235 - A235
  • [48] Real-Life Efficacy and Safety of IDegLira in Type 2 Diabetic Patients during COVID-19: A 6-Month Follow-Up by Teleconsultation in Bucaramanga, Colombia
    Parra Serrano, Gustavo A.
    Torreslanghammer, Maria Paula
    Serranogomez, Sergio
    Pintoarias, Andrea J.
    DIABETES, 2021, 70
  • [49] HYBRID THERAPY IN YOUTH WITH TYPE 1 DIABETES - CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) COMBINED WITH LONG-ACTING INSULIN: A REAL-LIFE EXPERIENCE
    Lerman, L.
    Barash, G.
    Ben-Ari, T.
    Abiri, S.
    Landau, Z.
    Brener, A.
    Lebenthal, Y.
    Pinhas-Hamiel, O.
    Mazor-Aronovithch, K.
    Haim, A.
    Yeshayahu, Y.
    De Vries, L.
    Rachmiel, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A70 - A71
  • [50] Ramadan Fasting in Diabetes Patients on Insulin Pump Therapy Augmented by Continuous Glucose Monitoring: An Observational Real-Life Study
    Khalil, Ali Bernard
    Beshyah, Salem A.
    Abu Awad, Samar M.
    Benbarka, Mahmoud M.
    Haddad, Marcil
    Al-Hassan, Dana
    Kahwatih, Marwa
    Nagelkerke, Nico
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (09) : 813 - 818